Welcome to our dedicated page for Archer Daniels Midland Co news (Ticker: ADM), a resource for investors and traders seeking the latest updates and insights on Archer Daniels Midland Co stock.
Archer Daniels Midland Company (ADM) is a global leader in agricultural processing and commodity trading, transforming crops into essential food, feed, and industrial products. This page serves as a comprehensive resource for ADM-related news, offering investors and industry professionals timely updates on corporate developments and market activities.
Access the latest press releases, earnings reports, and strategic announcements from one of the world's largest agricultural supply chain managers. Our curated collection ensures you stay informed about ADM's operational milestones, sustainability initiatives, and innovations in nutrition solutions without promotional bias.
Key coverage areas span quarterly financial results, supply chain expansions, partnership announcements, and industry leadership updates. The content reflects ADM's role in global food security, renewable energy projects, and agricultural technology advancements.
Bookmark this page for direct access to verified ADM news sources, enabling efficient tracking of market-moving developments. Check back regularly for objective reporting on how ADM navigates commodity markets, environmental commitments, and evolving consumer demands across 140+ countries.
ADM announces a significant equity investment in Acies Bio, a Slovenia-based biotechnology firm, to enhance its capabilities in precision microbial fermentation. This partnership aims to advance innovative, sustainable solutions in agriculture and food production. ADM's investment, through its corporate venture arm, ADM Ventures, will help accelerate Acies Bio’s platform technologies, improving their infrastructure and high-throughput capabilities. This collaboration opens new growth opportunities in the microbial technology sector, aligning with ADM's commitment to sustainability.
ADM (NYSE: ADM) has agreed to sell its ethanol production complex in Peoria, Illinois, to BioUrja Group. This divestiture will reduce ADM's ethanol capacity by 135 million gallons, allowing the company to redeploy capital into strategic growth investments. CEO Juan Luciano emphasized that this sale aligns with ADM's ongoing transformation and sustainable growth strategy. The transition will be smooth for the approximately 150 employees at the Peoria facility. BioUrja Group looks forward to enhancing its bio-ethanol production capabilities and contributing to the global energy transition.
On October 19, 2021, Solarea Bio, a biotech firm from Cambridge, MA, announced a technology licensing agreement with ADM (NYSE: ADM). This partnership aims to harness microbial technologies developed by Solarea to address inflammatory conditions like osteoporosis. ADM will explore using these microbes in innovative food and beverage solutions targeting health and wellness. Both companies expressed enthusiasm about the collaboration and its potential to create impactful health solutions. This agreement underscores ADM's commitment to expanding its microbiome strategic platform for growth.
ADM, a leader in nutrition, has released its second annual list of global consumer trends based on insights from its Outside Voice platform. Key trends include a focus on holistic nourishment, plant-based diets, gut health awareness, clean sourcing demands, and the humanization of pets. The report highlights consumers' desires for transparency, sustainability, and responsible animal feeding. These insights aim to guide product innovation for brands seeking relevance in an evolving marketplace, reflecting a significant shift in consumer values and behaviors.
ADM (NYSE: ADM) and Qingdao Vland Biotech Group have announced a joint venture aimed at capturing the demand for human probiotics in China. Retail demand for probiotics in China is projected to reach $1 billion in 2022, growing at over 9% annually. The 50-50 joint venture will manufacture and sell human probiotics, leveraging the expertise and capabilities of both companies. Regulatory approval is needed for the venture, which is expected to launch in the first half of 2022. This partnership forms part of ADM's broader strategy to expand its health and wellness portfolio.
ADM Achieves Recognition for Protein Innovation
ADM (NYSE: ADM) has been ranked 27th on Fortune's 2021 Change the World list, recognizing companies with significant social impact. For over 70 years, ADM has led in protein innovation, creating the first plant-based meat alternative and soy-based patty. As a leader in sustainable food sources, ADM is committed to developing nutritious foods for a growing population. They aim to address the need for diverse protein sources, with the goal of producing 60% more food by 2050 to meet global demands.
ADM will release its third quarter 2021 financial results on
For more information, visit www.adm.com.
ADM (NYSE: ADM) will host a global investor day on Friday, Dec. 10, featuring Chairman and CEO Juan Luciano and CFO Ray Young, who will highlight ADM's strategic achievements and outline the company's growth plan. Further details will be provided in the coming weeks. ADM is a global leader in nutrition, offering innovative solutions for human and animal needs, and emphasizes sustainability in its operations. The investor day aims to share insights on the company's transformation and future direction.
ADM has launched a new automated flavor production facility in Pinghu, Zhejiang Province, China. This 27,000+ square meter facility is designed to be the flavor supply hub for ADM in the Asia-Pacific region, providing geographic advantages and access to top talent.
With advanced technologies and certifications, the facility aims to meet the growing demand for healthy food products. ADM emphasizes its ongoing commitment to growth through strategic acquisitions and technological innovations to support its global nutrition division.
ADM and LG Chem have signed a memorandum of understanding to explore the production of lactic acid in the US, aiming to meet rising demand for plant-based products, including bioplastics.
The joint venture is expected to begin in early 2022, producing high-purity, corn-based lactic acid. The global lactic acid market was valued at